Orange Book product · Generic (ANDA)
SCANDONEST L
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
At a glance
Oct 10, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 10, 1984
42 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
Strength
0.05MG/ML;2%
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 088388
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
- —CARBOCAINE W/ NEO-COBEFRINBrand (NDA)
NDA 012125 · EASTMAN KODAK
- 1988POLOCAINE W/ LEVONORDEFRINGeneric (ANDA)
ANDA 089517 · DENTSPLY PHARM
- 1983MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRINGeneric (ANDA)
ANDA 084850 · BELMORA LLC
- —ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRINGeneric (ANDA)
ANDA 085010 · SOLVAY
- —ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRINGeneric (ANDA)
ANDA 084697 · SEPTODONT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
